ArticleEClinicalMedicine2023

Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial.

Xiaoqiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.